Edinburgh Molecular Imaging
2 known investors
Find your way into Edinburgh Molecular Imaging
University of Edinburgh spin-out clinical-phase biotech developing C-Met molecular targeting technology for cancer radiotherapy and imaging.
Investors · 2
In the news
Frequently asked questions
- What does Edinburgh Molecular Imaging do?
- University of Edinburgh spin-out clinical-phase biotech developing C-Met molecular targeting technology for cancer radiotherapy and imaging.
- Who are Edinburgh Molecular Imaging's investors?
- Edinburgh Molecular Imaging's investors include Epidarex Capital, Scottish Investment Bank.